What is the prevalence of Phyllodes tumor?

Phyllodes tumors are rare fibroepithelial neoplasms of the breast, accounting for less than 1% of all breast tumors, with an estimated incidence of approximately 2.1 cases per million women per year.

Epidemiology and Distribution

Because Phyllodes tumor is classified as a rare condition, exact global prevalence statistics are difficult to pinpoint. While the incidence is low, the clinical reality is that Phyllodes tumor typically presents in women between the ages of 35 and 55. Although rare, these tumors can occur in adolescents and older adults as well. While they are overwhelmingly diagnosed in females, there have been extremely rare documented cases of Phyllodes tumor in males, usually associated with gynecomastia or hormonal imbalances.

Challenges in Data Collection

The true prevalence of Phyllodes tumor is likely higher than reported in current literature due to the historical tendency to misdiagnose these lesions as fibroadenomas. Because they share clinical and radiological features with more common benign breast conditions, many cases may remain undiagnosed or misclassified in national cancer registries. There is currently no definitive evidence suggesting significant geographic or ethnic variations in the prevalence of this condition; however, limited global surveillance makes it difficult to rule out regional disparities.

Real-World Perspectives

Data from the Phyllodes tumor community on DiseaseMaps.org provides a crucial, real-world perspective that complements traditional clinical studies. By aggregating the lived experiences of over 1,000 members, DiseaseMaps.org helps bridge the gap between clinical textbooks and the actual patient journey, highlighting the diagnostic delays and the emotional toll that accompany this rare diagnosis. Engaging with such communities is essential for patients navigating the complexities of Phyllodes tumor care.

Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• National Cancer Institute (NCI) Physician Data Query (PDQ) on Phyllodes Tumors